MDGL logo

Madrigal Pharmaceuticals (MDGL) return on equity

annual ROE:

-80.35%+43.63%(+35.19%)
December 31, 2024

Summary

  • As of today (July 3, 2025), MDGL annual return on equity is -80.35%, with the most recent change of +43.63% (+35.19%) on December 31, 2024.
  • During the last 3 years, MDGL annual ROE has risen by +30.57% (+27.56%).
  • MDGL annual ROE is now -125.31% below its all-time high of 317.48%, reached on December 31, 2009.

Performance

MDGL ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLprofitability metrics

quarterly ROE:

-49.57%+14.34%(+22.44%)
March 31, 2025

Summary

  • As of today (July 3, 2025), MDGL quarterly return on equity is -49.57%, with the most recent change of +14.34% (+22.44%) on March 31, 2025.
  • Over the past year, MDGL quarterly ROE has increased by +95.43% (+65.81%).
  • MDGL quarterly ROE is now -101.40% below its all-time high of 3532.29%, reached on March 31, 2010.

Performance

MDGL quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

MDGL ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+35.2%+65.8%
3 y3 years+27.6%+55.5%
5 y5 years-327.6%-104.7%

MDGL ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+46.5%at high+86.2%
5 y5-year-327.6%+46.5%-50.7%+86.2%
alltimeall time-125.3%+85.3%-101.4%+96.4%

MDGL ROE History

DateAnnualQuarterly
Mar 2025
-
-49.57%(-22.4%)
Dec 2024
-80.35%(-35.2%)
-63.91%(-28.2%)
Sep 2024
-
-89.04%(-21.9%)
Jun 2024
-
-113.99%(-21.4%)
Mar 2024
-
-145.00%(-31.8%)
Dec 2023
-123.98%(-17.4%)
-212.62%(-40.8%)
Sep 2023
-
-358.86%(+18.7%)
Jun 2023
-
-302.44%(+12.9%)
Mar 2023
-
-267.87%(+14.9%)
Dec 2022
-150.12%(+35.3%)
-233.13%(+14.2%)
Sep 2022
-
-204.19%(+48.6%)
Jun 2022
-
-137.44%(+23.4%)
Mar 2022
-
-111.39%(+10.7%)
Dec 2021
-110.92%(+80.0%)
-100.59%(+10.3%)
Sep 2021
-
-91.23%(+10.7%)
Jun 2021
-
-82.38%(+14.4%)
Mar 2021
-
-71.99%(+19.2%)
Dec 2020
-61.61%(+227.9%)
-60.38%(+32.5%)
Sep 2020
-
-45.56%(+38.5%)
Jun 2020
-
-32.89%(+35.8%)
Mar 2020
-
-24.22%(+30.4%)
Dec 2019
-18.79%(+88.8%)
-18.58%(+27.7%)
Sep 2019
-
-14.55%(+26.0%)
Jun 2019
-
-11.55%(+16.3%)
Mar 2019
-
-9.93%(+9.2%)
Dec 2018
-9.95%(-65.1%)
-9.09%(-15.6%)
Sep 2018
-
-10.77%(-30.1%)
Jun 2018
-
-15.41%(-50.1%)
Mar 2018
-
-30.91%(-26.8%)
Dec 2017
-28.49%(-60.7%)
-42.21%(-37.8%)
Sep 2017
-
-67.87%(-20.5%)
Jun 2017
-
-85.38%(+8.2%)
Mar 2017
-
-78.91%(-33.6%)
Dec 2016
-72.47%(-14.1%)
-118.87%(+56.3%)
Sep 2016
-
-76.03%(+205.7%)
Jun 2016
-
-24.87%(-66.3%)
Mar 2016
-
-73.71%(-36.0%)
Dec 2015
-84.39%(-44.1%)
-115.25%(+19.3%)
Sep 2015
-
-96.59%(-19.2%)
Jun 2015
-
-119.57%(-11.8%)
Mar 2015
-
-135.59%(-2.4%)
Dec 2014
-150.86%
-138.89%(-19.8%)
DateAnnualQuarterly
Sep 2014
-
-173.25%(-20.8%)
Jun 2014
-
-218.87%(-8.7%)
Mar 2014
-
-239.79%(+22.7%)
Dec 2013
-145.29%(+3.9%)
-195.38%(-0.7%)
Sep 2013
-
-196.70%(+12.8%)
Jun 2013
-
-174.36%(+11.1%)
Mar 2013
-
-156.97%(-11.9%)
Dec 2012
-139.78%(-43.6%)
-178.11%(-19.1%)
Sep 2012
-
-220.27%(+7.8%)
Jun 2012
-
-204.37%(-1.7%)
Mar 2012
-
-208.01%(-1.3%)
Dec 2011
-247.72%(+60.0%)
-210.82%(+14.9%)
Sep 2011
-
-183.52%(+15.1%)
Jun 2011
-
-159.45%(+14.3%)
Mar 2011
-
-139.54%(+14.4%)
Dec 2010
-154.85%(-148.8%)
-122.00%(+10.0%)
Sep 2010
-
-110.87%(-111.0%)
Jun 2010
-
1005.82%(-71.5%)
Mar 2010
-
3532.29%(-1372.4%)
Dec 2009
317.48%(+101.5%)
-277.61%(+128.0%)
Sep 2009
-
-121.77%(-195.1%)
Jun 2009
-
128.11%(-39.9%)
Mar 2009
-
213.20%(-46.5%)
Dec 2008
157.54%(-128.7%)
398.84%(-129.0%)
Sep 2008
-
-1375.78%(+354.8%)
Jun 2008
-
-302.47%(+83.6%)
Mar 2008
-
-164.70%(-4.4%)
Dec 2007
-548.58%(+143.0%)
-172.34%(-3.3%)
Sep 2007
-
-178.16%(+9.6%)
Jun 2007
-
-162.52%(+30.5%)
Mar 2007
-
-124.52%(-10.3%)
Dec 2006
-225.78%(+179.4%)
-138.81%(+27.9%)
Sep 2006
-
-108.50%(-21.0%)
Jun 2006
-
-137.27%(-14.0%)
Mar 2006
-
-159.67%(+41.4%)
Dec 2005
-80.81%(+71.4%)
-112.96%(+60.3%)
Sep 2005
-
-70.48%(+59.9%)
Jun 2005
-
-44.07%(+149.4%)
Mar 2005
-
-17.67%
Dec 2004
-47.15%(-32.7%)
-
Dec 2003
-70.01%(+404.4%)
-
Dec 2001
-13.88%
-

FAQ

  • What is Madrigal Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals annual ROE year-on-year change?
  • What is Madrigal Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly ROE year-on-year change?

What is Madrigal Pharmaceuticals annual return on equity?

The current annual ROE of MDGL is -80.35%

What is the all time high annual ROE for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual return on equity is 317.48%

What is Madrigal Pharmaceuticals annual ROE year-on-year change?

Over the past year, MDGL annual return on equity has changed by +43.63% (+35.19%)

What is Madrigal Pharmaceuticals quarterly return on equity?

The current quarterly ROE of MDGL is -49.57%

What is the all time high quarterly ROE for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly return on equity is 3532.29%

What is Madrigal Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, MDGL quarterly return on equity has changed by +95.43% (+65.81%)
On this page